中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Mechanism underlying the anti-angiogenetic effect of the novel tubulin inhibitor C9

文献类型:期刊论文

作者Ren Xuan; Lin Liping; Ding Jian
刊名Chinese Journal New Drugs
出版日期2011
卷号20期号:17页码:1703-1711
关键词C9 C9 angiogenesis endothelial cell MAPK pathway
ISSN号1003-3734
其他题名微管抑制剂C9抑制新生血管生成的作用机
文献子类Article
英文摘要Objective: To investigate mechanism underlying the anti-angiogenetic effect of C9, a new tubulin inhibitor.Methods:Antagonizing effect of C9 on anti-apoptotic activity of VEGF and bFGF was determined by FACS and TUNEL assay in endothelial cells cultured in serum-free media.Phosphorylation of c-Raf,Mek,Erk and Akt was detected by Western blot after treatment with various concentrations of C9.Results:FACS and TUNEL assay showed that C9 antagonized the anti-apoptosis activity of VEGF and bFGF on apoptosis induced by serum-free culture in endothelial cells.Western Blot revealed that C9 at various concentrations downregulated phosphorylation of c-Raf,Mek,Erk and Akt,but did not affect the phosphorylation of KDR or FGFR1.Conclusion:C9 inhibits the angiogenesis process by targeting the Raf-Mek-Erk-MAPK pathway.
资助项目国家自然科学基金[00000000]
WOS研究方向Pharmacology & Pharmacy (provided by Clarivate Analytics)
语种中文
CSCD记录号CSCD:4332067
源URL[http://119.78.100.183/handle/2S10ELR8/267903]  
专题科研与新药推进处
通讯作者Lin Liping
作者单位State Key Laboratory of Drug Research, Shanghai Institute of Materia Medidca,Chinese Academy of Sciences, Shanghai 201203, China.
推荐引用方式
GB/T 7714
Ren Xuan,Lin Liping,Ding Jian. Mechanism underlying the anti-angiogenetic effect of the novel tubulin inhibitor C9[J]. Chinese Journal New Drugs,2011,20(17):1703-1711.
APA Ren Xuan,Lin Liping,&Ding Jian.(2011).Mechanism underlying the anti-angiogenetic effect of the novel tubulin inhibitor C9.Chinese Journal New Drugs,20(17),1703-1711.
MLA Ren Xuan,et al."Mechanism underlying the anti-angiogenetic effect of the novel tubulin inhibitor C9".Chinese Journal New Drugs 20.17(2011):1703-1711.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。